Home Your basket
• Possible role of biofilm ...
   Price 10.50 €
• PET/CT in the management ...
   Price 10.50 €
• Evaluation of rhinologic ...
   Price 10.50 €
• Middle ear tuberculosis e...
   Price 5.50 €
• Clinical Practice Guideli...
   Price 12.00 €
• Nasal cutaneous cryptococ...
   Price 5.50 €
• Epidermoid carcinoma of p...
   Price 10.50 €
• Hearing aid : practical a...
   Price 8.50 €
• Bullet in the pharynx: En...
   Price 10.50 €
• Notes on voice and speech...
   Price 8.50 €
• Tympanoplasty: Experience...
   Price 12.00 €
• A survey of current wound...
   Price 5.50 €
• Osteointegrated cranio-fa...
   Price 10.50 €
• Combined approach (extern...
   Price 10.50 €
• Identification and locali...
   Price 8.50 €
• Vertigo and pathology of ...
   Price 10.50 €
• Evolution of voice assess...
   Price 10.50 €
• Usher type I syndrome in ...
   Price 10.50 €
• Adolescence and cochlear ...
   Price 10.50 €
• Paraganglioma of the cere...
   Price 5.50 €
• The place of anti-viral i...
   Price 10.50 €
• Metastatic angiosarcoma t...
   Price 5.50 €
• Hypersensitivity to inhal...
   Price 10.50 €
• Correlation between laryn...
   Price 10.50 €
• Hearing evaluation on you...
   Price 8.50 €
• Post operative Caldwell-L...
   Price 10.00 €
• Middle ear osteoma: A rar...
   Price 8.50 €
• Multiple intracranial epi...
   Price 14.00 €
• Peptide receptor radionuc...
   Price 14.00 €
• Isolated congenital trach...
   Price 10.50 €
• Cat scratch disease: A di...
   Price 8.50 €
• Parathyroïd adenoma induc...
   Price 8.50 €
• A single appointment with...
   Price 8.50 €
• Spontaneous subcutaneous ...
   Price 5.50 €
• IPSEN Foundation meeting:...
   Price 5.50 €
• Migrating hypopharyngeal ...
   Price 5.50 €

Total Order 331.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 4 - 2001 o

HEAD AND NECK SURGERY

Utility of positron emission tomography for follow-up after therapy of head and neck squamous cell carcinomas


Authors : Cl. Conessa, Ph. Clement, H. Foehrenbach, Ph. Maszelin, P. Verdalle, M. Kossowski, J.-L. Poncet (Paris)

Ref. : Rev Laryngol Otol Rhinol. 2001;122,4:253-258.

Article published in french
Downloadable PDF document french



Summary : This study aimed at pointing out the supply of the positron emission tomography (PET) in the posttherapeutic follow-up of the head and neck squamous cell carcinomas and to determine the best period to perform this test. Patients and methods: twenty patients have been included in this series, 16 men and 4 women. The PET was performed between 3 and 6 months after the end of all therapy. It systematically included radiation therapy. The results of the PET have been compared with those obtained by histology. The average distance of the follow-up of the patients after the achievement of the test was 11 months. Results: they divided up according to the presence or not of an abnormal fixation on the PET imaging. Negative PETs: eigth cases. Among those, a patient showed a metastatic cervical adenopathy at five months. Positive PETs: twelve cases which can be divided into three groups according to the area of the fixation. Primary site: 8 cases, 4 of which false-positive. Cervical lymph nodes: one case. Other sites: three cases. In our series PET had a sensitivity of 87% and a specificity of 67%. Conclusion: the PET is an original imaging as it allows a corporal metabolic study at one go. It seems to be very useful in the follow-up of patients who show a head and neck squamous cell carcinoma.The best period to perform it is the third or fourth posttherapeutic month. The high sensitivity is interesting within the context of an early detection of a residual tumour, for it allows to think of a suitable therapy quicker.

Price : 8.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE